Nanobiotech Lab, Department of Zoology, Kirori Mal College, University of Delhi, India
Dr. Anita Kamra Verma is an Associate Professor works in Molecular Toxicology Research Laboratory, NIH-RCMI Center for Environmental Health, CSET, Jackson State University, Jackson, MS, USA
Hypothesis
Nano-theragnostic Approach to Mitigate Covid-19
Author(s): Anita Kamra Verma*
Global Coronavirus pandemic has to be strategically addressed. The initial preventive phase has been largely discussed. The gamut of disease is comprehensive as patients hospitalised with COVID-19 manifest respiratory failure, sepsis, pneumonia, and acute respiratory distress syndrome (ARDS). Nano-theragnostics might have the answer to the mightiest challenge of this century in the next phase of diagnostics and therapeutics. Coronavirus causes severe morbidity in the lower respiratory tract, where alveolar epithelial cells are the key targets for dysregulating their function and triggering immune responses. The intensity and continued production of cytokine rush leads to enhanced vascular hyperpermeability that often causes multiorgan failure, and finally death. Nanoparticles (NPs) are being envisaged to target the airway epithelial cells to repair the dysfunctions with therapy, drug .. View more»